Sudden Death of an Infant with Heterotaxy Syndrome: an Autopsy Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
New Jersey Chapter American College of Physicians
NEW JERSEY CHAPTER AMERICAN COLLEGE OF PHYSICIANS ASSOCIATES ABSTRACT COMPETITION 2015 SUBMISSIONS 2015 Resident/Fellow Abstracts 1 1. ID CATEGORY NAME ADDITIONAL PROGRAM ABSTRACT AUTHORS 2. 295 Clinical Abed, Kareem Viren Vankawala MD Atlanticare Intrapulmonary Arteriovenous Malformation causing Recurrent Cerebral Emboli Vignette FACC; Qi Sun MD Regional Medical Ischemic strokes are mainly due to cardioembolic occlusion of small vessels, as well as large vessel thromboemboli. We describe a Center case of intrapulmonary A-V shunt as the etiology of an acute ischemic event. A 63 year old male with a past history of (Dominik supraventricular tachycardia and recurrent deep vein thrombosis; who has been non-compliant on Rivaroxaban, presents with Zampino) pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. The deep vein thrombosis and pulmonary embolus were not significant enough to warrant ultrasound-enhanced thrombolysis by Ekosonic EndoWave Infusion Catheter System, and the patient was subsequently restarted on Rivaroxaban and discharged. The patient presented five days later with left arm tightness and was found to have multiple areas of punctuate infarction of both cerebellar hemispheres, more confluent within the right frontal lobe. Of note he was compliant at this time with Rivaroxaban. The patient was started on unfractionated heparin drip and subsequently admitted. On admission, his vital signs showed a blood pressure of 138/93, heart rate 65 bpm, and respiratory rate 16. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs or gallops and his lungs were clear to auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities, mild dysmetria in the left upper extremity and an NIH score of 1. -
Prioritization of Health Services
PRIORITIZATION OF HEALTH SERVICES A Report to the Governor and the 74th Oregon Legislative Assembly Oregon Health Services Commission Office for Oregon Health Policy and Research Department of Administrative Services 2007 TABLE OF CONTENTS List of Figures . iii Health Services Commission and Staff . .v Acknowledgments . .vii Executive Summary . ix CHAPTER ONE: A HISTORY OF HEALTH SERVICES PRIORITIZATION UNDER THE OREGON HEALTH PLAN Enabling Legislatiion . 3 Early Prioritization Efforts . 3 Gaining Waiver Approval . 5 Impact . 6 CHAPTER TWO: PRIORITIZATION OF HEALTH SERVICES FOR 2008-09 Charge to the Health Services Commission . .. 25 Biennial Review of the Prioritized List . 26 A New Prioritization Methodology . 26 Public Input . 36 Next Steps . 36 Interim Modifications to the Prioritized List . 37 Technical Changes . 38 Advancements in Medical Technology . .42 CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES Practice Guidelines . 47 Age-Related Macular Degeneration (AMD) . 47 Chronic Anal Fissure . 48 Comfort Care . 48 Complicated Hernias . 49 Diagnostic Services Not Appearing on the Prioritized List . 49 Non-Prenatal Genetic Testing . 49 Tuberculosis Blood Test . 51 Early Childhood Mental Health . 52 Adjustment Reactions In Early Childhood . 52 Attention Deficit and Hyperactivity Disorders in Early Childhood . 53 Disruptive Behavior Disorders In Early Childhood . 54 Mental Health Problems In Early Childhood Related To Neglect Or Abuse . 54 Mood Disorders in Early Childhood . 55 Erythropoietin . 55 Mastocytosis . 56 Obesity . 56 Bariatric Surgery . 56 Non-Surgical Management of Obesity . 58 PET Scans . 58 Prenatal Screening for Down Syndrome . 59 Prophylactic Breast Removal . 59 Psoriasis . 59 Reabilitative Therapies . 60 i TABLE OF CONTENTS (Cont’d) CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES (CONT’D) Practice Guidelines (Cont’d) Sinus Surgery . -
Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck. -
Supermicar Data Entry Instructions, 2007 363 Pp. Pdf Icon[PDF
SUPERMICAR TABLE OF CONTENTS Chapter I - Introduction to SuperMICAR ........................................... 1 A. History and Background .............................................. 1 Chapter II – The Death Certificate ..................................................... 3 Exercise 1 – Reading Death Certificate ........................... 7 Chapter III Basic Data Entry Instructions ....................................... 12 A. Creating a SuperMICAR File ....................................... 14 B. Entering and Saving Certificate Data........................... 18 C. Adding Certificates using SuperMICAR....................... 19 1. Opening a file........................................................ 19 2. Certificate.............................................................. 19 3. Sex........................................................................ 20 4. Date of Death........................................................ 20 5. Age: Number of Units ........................................... 20 6. Age: Unit............................................................... 20 7. Part I, Cause of Death .......................................... 21 8. Duration ................................................................ 22 9. Part II, Cause of Death ......................................... 22 10. Was Autopsy Performed....................................... 23 11. Were Autopsy Findings Available ......................... 23 12. Tobacco................................................................ 24 13. Pregnancy............................................................ -
2018 Southern Regional Meeting
Abstracts J Investig Med: first published as 10.1136/jim-2017-000697.1 on 1 February 2018. Downloaded from Cardiovascular club I Purpose of study Coronary artery disease (C.A.D.) is one of the highest causes of death in the world. The purpose of this 11:00 AM study is to compare Puerto Rico (P.R.), Hispanic, U.S.A. coun- try, with the U.S.A., in coronary artery disease. Thursday, February 22, 2018 Methods used Compare a population of Hispanics with the high LDL levels with normal total cholesterol and HDL in P. R. and the U.S.A. The study population was 1000 patients. 1 A POSSIBLE ROLE FOR GENETICS IN CARDIOVASCULAR The U.S.A. health statistics and P.R. Department of Health DISEASE AMONG THE ACADIANS was used for comparison. AE Tedesco*, Z Haq, KL Di Losa, MJ Ali, P Gregory. LSUHSC – New Orleans, New Orleans, Summary of results Studying the lipid profile of Puerto Rico LA population, we found that the mean value of LDL lipoprotein is high (±104 mg/dl) with similar cholesterol and HDL levels 10.1136/jim-2017-000697.1 in both societies; still the coronary disease (CAD) incidence is lower than the U.S.A. (20%–30%). Investigators from the U.P. Purpose of study It is well documented that the Louisiana Aca- R. reported the genetic admixture of this Hispanic population. ‘ ’ dians ( Cajuns ) experience a disproportionate risk for some They reported the admixture consisted of 3 genes called pro- genetic diseases due to a genetic founder effect.Furthermore, cer- tective against C.A.D. -
Heterotaxy: Associated Conditions and Hospital- Based Prevalence in Newborns Angela E
May/June 2000. Vol. 2 . No. 3 Heterotaxy: Associated conditions and hospital- based prevalence in newborns Angela E. Lin, MD',~,*, Baruch S. Ticho, MD, phD3j4,Kara Houde, MA1,Marie-Noel Westgate, ME^', and Lewis B. Holmes, MD',~,~ Purpose: To provide insight into the possible etiology and prevalence of heterotaxy, we studied conditions associated with heterotaxy in a consecutive hospital population of newborns. Methods: From 1972 to March, 1999 (except February 16, 1972 to December 31, 1978), 58 cases of heterotaxy were ascertained from a cohort of 201,084 births in the ongoing Active Malformation Surveillance Program at the Brigham and Women's Hospital. This registry includes livebirths, stillbirths, and elective abortions. Prevalence among nontransfers (i.e., patients whose mothers had planned delivery at this hospital) was calculated as approximately 1per 10,000 total births (20 of 201,084). Results: We analyzed a total of 58 patients consisting of 20 (34%) nontransfers and 38 (66%) transfers. Patients were categorized by spleen status as having asplenia (7 nontransfers, 25 total), polysplenia (8, 20), right spleen (4, ll),normal left (0, I), and unknown (1, 0). Among the 20 nontransfer and 59 total heterotaxy patients, the following associated medical conditions were present: chromosome abnormality (1nontransfer, 2 total), suspected Mendelian or chromosome microdeletion disorder (1nontransfer, 6 total), and maternal insulin- dependent diabetes mellitus (1 nontransfer, 2 total). There were 6 twins (1 member each from 6 twin pairs including 1dizygous, 4 monozygous, 1conjoined; 2 were nontransfers). An associated condition occurred in 5 (25%) nontransfer and 16 (28%) total patients, or among 10 of 53 singleton births (19%). -
PG Course Syllabus – FINAL
postgraduate course Atlanta,Georgia october 23, 2014 1 2 Table of Contents MODULE 1: LIVER PRIMARY SCLEROSING CHOLANGITIS – Dennis Black MD ................................................................. 13 THE JAUNDICED INFANT ‐ Saul Karpen MD ....................................................................................... 25 ACUTE LIVER FAILURE – Estella Alonso MD ....................................................................................... 43 MODULE 2: ENDOSCOPY THE DREADED WAKE‐UP CALL (PART A) – Mercedes Martinez MD .................................................. 55 THE DREADED WAKE‐UP CALL (PART B) – Lee Bass MD .................................................................... 67 ENDOSCOPIC INTERVENTIONS FOR BILIARY TRACT DISEASE – Victor Fox MD .................................. 75 MODULE 3: GI POTPOURRI EXTRAESOPHAGEAL MANIFESTATIONS OF GER – Benjamin Gold MD .............................................. 86 EoE: PPI, EGD AND WHAT TO EAT: ALPHABET DISTRESS – Sandeep Gupta MD ............................... 105 SNEW TRICK AND TREATMENTS FOR MOTILITY DISORDERS – Carlo Di Lorenzo MD ........................ 116 DIAGNOSIS AND MANAGEMENT OF CONSTIPATION – Manu Sood MD ........................................... 130 MODULE 4: NUTRITION DIET AND THE MICROBIOME – Robert Baldassano MD .................................................................... 141 FODMAP: NAVIGATING THIS NOVEL DIET – Bruno Chumpitazi MD .................................................. 152 NUTRITION EIN TH CHILD WITH NEUROLOGICAL DISABILITIES -
Asplenia and Polysplenia Syndromes with Abnormalities of Lateralisation in a Sibship
J Med Genet: first published as 10.1136/jmg.18.4.301 on 1 August 1981. Downloaded from Journal of Medical Genetics, 1981, 18, 301-302 Asplenia and polysplenia syndromes with abnormalities of lateralisation in a sibship J ZLOTOGORA AND E ELIAN From the Department ofPediatrics, Hasharon Hospital, Petah-Tiqva, and Tel-Aviv University Medical School, Israel SUMMARY In the family presented here the first child had asplenia syndrome with cor biloculare' transposition of the great vessels, pulmonary stenosis, and anomalous pulmonary venous drainage' Another sib had situs inversus with polysplenia syndrome, including very similar cardiovascular defects and biliary atresia. The possibility that these two syndromes, namely asplenia and poly- splenia, are different manifestations of a similar defect in the normal asymmetrical development of internal organs is discussed. Some degree of lateral asymmetry is one of the age and weighed 2060 g. At the age of 5 days she was characteristics of the internal human body con- noted to be cyanotic and a grade 3/6 systolic murmur figuration. A mirror image of the asymmetrical was heard along the left sternal border. At cardiac organs is found in situs inversus, while in the asplenia catheterisation, transposition of the great vessels with and polysplenia syndromes there is a striking ten- double outlet of the right ventricle and pulmonary dency for internal symmetry. In the asplenia stenosis were demonstrated. The child failed to copyright. (Ivemark) syndrome the tendency is for the left lung, thrive and died at 3 months of age following an atrium, and left lobe of the liver to resemble the episode of septicaemia. -
Accessory Spleen Mimicking Pancreatic Tumour: Evaluation by 99Mtc-Labelled Colloid SPECT/CT Study
Folia Morphol. Vol. 74, No. 4, pp. 532–539 DOI: 10.5603/FM.2015.0119 C A S E R E P O R T Copyright © 2015 Via Medica ISSN 0015–5659 www.fm.viamedica.pl Accessory spleen mimicking pancreatic tumour: evaluation by 99mTc-labelled colloid SPECT/CT study. Report of two cases and a review of nuclear medicine methods utility M. Pachowicz1, 2, A. Mocarska3, E. Starosławska3, Ł. Pietrzyk2, 4, B. Chrapko1 1Chair and Department of Nuclear Medicine, Medical University of Lublin, Poland 2Department of Didactics and Medical Simulation, Medical University of Lublin, Poland 3St. John’s Cancer Centre, Lublin, Poland 4General and Minimally Invasive Surgery Department, 1st Clinical Military Hospital, Lublin, Poland [Received 31 August 2014; Accepted 13 January 2015] The accessory spleen is a common congenital anomaly, typically asymptomatic and harmless to the patient. However, in some clinical cases, this anomaly beco- mes significant as it can be mistaken for a tumour or lymph node and be missed during a therapeutic splenectomy. There are nuclear medicine modalities which can be applied in the identification and localisation of an accessory spleen. They include scintigraphy with radiolabelled colloids or heat damaged red blood cells, which are trapped in the splenic tissue. Modern techniques, including hybrid imaging, enable simultaneous structure and tracer distribution evaluations. Additionally, radiation-guided surgery can be used in cases where the accessory spleen, which is usually small (not exceeding 1 cm) and difficult to find among other tissues, has to be removed. In the study, we would like to present 2 cases of patients in which the malignancy had to be excluded for the reason that the multiple accessory spleens were very closely related to the pancreas. -
ICD-9 Diagnosis Codes Effective 10/1/2014 (V32.0) Source: Centers for Medicare and Medicaid Services
ICD-9 Diagnosis Codes effective 10/1/2014 (v32.0) Source: Centers for Medicare and Medicaid Services 0010 Cholera d/t vib cholerae 0082 Aerobacter enteritis 01104 TB lung infiltr-cult dx 0011 Cholera d/t vib el tor 0083 Proteus enteritis 01105 TB lung infiltr-histo dx 0019 Cholera NOS 00841 Staphylococc enteritis 01106 TB lung infiltr-oth test 0020 Typhoid fever 00842 Pseudomonas enteritis 01110 TB lung nodular-unspec 0021 Paratyphoid fever a 00843 Int infec campylobacter 01111 TB lung nodular-no exam 0022 Paratyphoid fever b 00844 Int inf yrsnia entrcltca 01112 TB lung nodul-exam unkn 0023 Paratyphoid fever c 00845 Int inf clstrdium dfcile 01113 TB lung nodular-micro dx 0029 Paratyphoid fever NOS 00846 Intes infec oth anerobes 01114 TB lung nodular-cult dx 0030 Salmonella enteritis 00847 Int inf oth grm neg bctr 01115 TB lung nodular-histo dx 0031 Salmonella septicemia 00849 Bacterial enteritis NEC 01116 TB lung nodular-oth test 00320 Local salmonella inf NOS 0085 Bacterial enteritis NOS 01120 TB lung w cavity-unspec 00321 Salmonella meningitis 00861 Intes infec rotavirus 01121 TB lung w cavity-no exam 00322 Salmonella pneumonia 00862 Intes infec adenovirus 01122 TB lung cavity-exam unkn 00323 Salmonella arthritis 00863 Int inf norwalk virus 01123 TB lung w cavit-micro dx 00324 Salmonella osteomyelitis 00864 Int inf oth sml rnd vrus 01124 TB lung w cavity-cult dx 00329 Local salmonella inf NEC 00865 Enteritis d/t calicivirs 01125 TB lung w cavit-histo dx 0038 Salmonella infection NEC 00866 Intes infec astrovirus 01126 TB lung w cavit-oth -
Benign Diseases of the Spleen 7 8 Refaat B
111 2 3 10 4 5 6 Benign Diseases of the Spleen 7 8 Refaat B. Kamel 9 1011 1 2 3 4 5 6 7 8 9 2011 1 Aims ● Splenic conservation, various tech- 2 niques. 3 ● Identifying the value and functions of the ● Splenic injuries and management. 4 spleen in health and diseases. 5 ● The role of spleen in haematological dis- 6 orders (sickle cell disease, thalassaemia, Introduction 7 spherocytosis, idiopathic thrombocy- 8 topenic purpura). The spleen has always been considered a mys- 9 terious and enigmatic organ. Aristotle con- ● Haematological functions of the spleen 3011 cluded that the spleen was not essential for life. (haemopoiesis in myeloproliferative 1 As a result of this, splenectomy was undertaken disorders, red blood cell maturation, 2 lightly, without a clear understanding of subse- removal of red cell inclusions and 3 quent effects. Although Hippocrates described destruction of senescent or abnormal red 4 the anatomy of the spleen remarkably accu- cells) and immunological functions 5 rately, the exact physiology of the spleen con- (antibody production, removal of partic- 6 tinued to baffle people for more than a 1000 ulate antigens as well as clearance of 7 years after Hippocrates. The spleen was thought immune complex and phagocytosis 8 in ancient times to be the seat of emotions but (source of suppressor T cells, source 9 its real function in immunity and to remove of opsonin that promotes neutrophil 4011 time-expired blood cells and circulating phagocytosis and production of 1 microbes, has only recently been recognised. “tuftsin”). 2 3 ● Effects of splenectomy on haematologi- 4 cal and immunological functions. -
Aagenaes Syndrome. See Cholestasis- Lymphedema Syndrome ABCB4
Index A Adrenoleukodystrophy, neonatal, Anisakis, as gastritis cause, 52 Aagenaes syndrome. See Cholestasis- 274-275 Anthraquinone laxatives, adverse lymphedema syndrome Adriamycin murine model, 13, 17, 27 effects of, 139, 149 ABCB4 disease, 244-245 Agammaglobulinemia, X-linked, 80, 169 Antiangiogenic agents, as ABCBll disease, 240-241 Aganglionosis. See also Hirschsprung's hepatoblastoma treatment, 331 Abetalipoproteinemia, 69, 70 disease Antibiotics, as bile duct injury and Abscesses acquired, 145 loss cause, 226-227 crypt, ulcerative colitis-related, Ill, colonic atresia as diagnostic marker Anus 113 for, 22 atresia and stenosis of, 22-24 intestinal, Crohn's disease-related, 109 segmental, differentiated from development of, 25 perianal, 168 "skip" lesions, 137 fissures of, 109 Crohn's disease-related, 109 Alagille syndrome, 209, 221-224, 274 APECED syndrome, 83-84 Achalasia, anal, 137 bile duct paucity associated with, 210 Apolipoproteins, 69 Acid maltase deficiency. See Glycogen biliary atresia-related, 210 Appendicitis storage diseases, type II differentiated from nonsyndromic Burkitt's lymphoma-related, 174 Acquired immunodeficiency syndrome paucity of bile ducts, 227-228 mesenteric cysts as mimic of, 172 (AIDSj, conditions associated as hepatocellular carcinoma cause, 278 Appendix, carcinoid tumors of, 171 with liver disease associated with, 221 Arteriovenous malformations, hepatic, adenovirus infections, 107 liver histopathology in, 222-224, 314 anti-enterocyte antibodies, 78, 79-80 225, 226 Arthritis, inflammatory bowel disease